Hormone in Yaz® Linked To Higher Risk Of Blood Clots

December 8, 2011

On the heels of research suggesting newer birth control pills may pose more of a risk for blood clots than older contraceptives, regulators with the Food and Drug Administration (FDA) are requiring a warning label update be made for newer contraceptive pills, ABC 11 News reported Tuesday.

A synthetic hormone known as drospirenone is at the center of the debate. It was marketed to drug manufacturers several years ago as having fewer side effects than active ingredients previously used in the drugs. Now, several large independent studies have shown that drugs containing the hormone may put users at a greater risk of developing potentially fatal blood clots.

Although the FDA has determined that the study’s results are inconclusive, they felt that the information should be included in the warning labels. Today, the agency is asking for the opinions of experts to help determine whether or not some women should not be allowed to use the medications.

The North Carolina Yaz® Injury Lawyers with HensonFuerst often deal with cases involving drug injuries. If you have been injured by taking the drug Yaz®, contact us with questions regarding your case today.